The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...

F2G has raised $100 million to advance its lead antifungal drug, olorofim, despite a setback with the FDA requesting further ...

The US FDA has granted Kite’s Yescarta (axicabtagene ciloleucel) a Regenerative Medicine Advanced Therapy (RMAT) designation ...

Japanese biopharma firm PeptiDream says that its wholly-owned PDRadiopharma subsidiary has entered into a strategic ...

US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer ...

Teva Pharmaceutical and mAbxience have signed a second global licensing deal to develop an anti PD-1 oncology biosimilar. The ...

French drug developer Abivax today announced the results of an interim efficacy and safety analysis of an open-label ...

Kedrion Biopharma has finalized a long-term agreement with Biotest, now part of Grifols, to commercialize and distribute ...

Ferring Pharmaceuticals has opened a global manufacturing hub in Finland to produce the drug substance for Adstiladrin, its ...

Caliway Biopharmaceuticals raised NT$6.4 billion ($206 million) in Taiwan’s largest biotech IPO, positioning the company at a ...

The US Food and Drug Administration (FDA) has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 ...

AstraZeneca's supplemental New Drug Application for Calquence (acalabrutinib) has been granted Priority Review by the US FDA ...